RESUMEN
Systemic contact dermatitis (SCD) develops when a person who was previously sensitized to an allergen is exposed to the same allergen via the systemic route. In East Asia, the use of lacquer for polishing furniture is common and a part of the traditional culture. Contact exposure to tableware polished with Rhus lacquer may lead to sensitization. In Korea, SCD is commonly observed after systemic exposure to Rhus, a nutritious food item consumed because of the common belief of it improving the immune system. In this study, we reviewed the medical records of 21 Korean patients with SCD caused by Rhus ingestion. We found that the most significant epidemiological factor for SCD was the season of the year. Furthermore, 66.67% of the patients presented with leucocytosis and 23.81% showed increased liver enzyme levels. It is important to educate people on the risks associated with the systemic ingestion of Rhus.
Asunto(s)
Dermatitis por Contacto/etiología , Dermatitis por Toxicodendron/diagnóstico , Exposición Dietética/efectos adversos , Rhus/efectos adversos , Corticoesteroides/uso terapéutico , Adulto , Anciano , Alérgenos/inmunología , Dermatitis por Toxicodendron/tratamiento farmacológico , Dermatitis por Toxicodendron/epidemiología , Dermatitis por Toxicodendron/inmunología , Dieta Vegetariana/efectos adversos , Quimioterapia Combinada , Femenino , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Incidencia , Masculino , Persona de Mediana Edad , República de Corea , Estudios Retrospectivos , Rhus/inmunología , Estaciones del AñoRESUMEN
In the United States, poison ivy exposure is the most common naturally occurring allergen to cause allergic contact dermatitis (ACD). The immune and pruritic mechanisms associated with poison ivy ACD remain largely unexplored. Here, we compared skin whole transcriptomes and itch mediator levels in mouse ACD models induced by the poison ivy allergen, urushiol, and the synthetic allergen, oxazolone. The urushiol model produced a Th2-biased immune response and scratching behavior, resembling findings in poison ivy patients. Urushiol-challenged skin contained elevated levels of the cytokine thymic stromal lymphopoietin (TSLP), a T-cell regulator and itch mediator, and pruritogenic serotonin (5-HT) and endothelin (ET-1), but not substance P (SP) or histamine. The oxazolone model generated a mixed Th1/Th2 response associated with increased levels of substance P, 5-HT, ET-1, but not TSLP or histamine. Injections of a TSLP monoclonal neutralizing antibody, serotonergic or endothelin inhibitors, but not SP inhibitors or antihistamines, reduced scratching behaviors in urushiol-challenged mice. Our findings suggest that the mouse urushiol model may serve as a translational model of human poison ivy ACD study. Inhibiting signaling by TSLP and other cytokines may represent alternatives to the standard steroid/antihistamine regimen for steroid-resistant or -intolerant patients and in exaggerated systemic responses to poison ivy.
Asunto(s)
Citocinas/metabolismo , Dermatitis por Toxicodendron/inmunología , Prurito/inmunología , Células Th2/inmunología , Toxicodendron/inmunología , Alérgenos/inmunología , Animales , Catecoles/inmunología , Citocinas/antagonistas & inhibidores , Citocinas/inmunología , Dermatitis por Toxicodendron/complicaciones , Dermatitis por Toxicodendron/tratamiento farmacológico , Modelos Animales de Enfermedad , Perfilación de la Expresión Génica , Humanos , Mediadores de Inflamación/metabolismo , Masculino , Ratones , Oxazolona/inmunología , Prurito/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Transducción de Señal/inmunología , Piel/efectos de los fármacos , Piel/inmunología , Piel/metabolismo , Células Th2/metabolismo , Toxicodendron/química , Linfopoyetina del Estroma TímicoRESUMEN
CD1a is a lipid-presenting molecule that is abundantly expressed on Langerhans cells. However, the in vivo role of CD1a has remained unclear, principally because CD1a is lacking in mice. Through the use of mice with transgenic expression of CD1a, we found that the plant-derived lipid urushiol triggered CD1a-dependent skin inflammation driven by CD4(+) helper T cells that produced the cytokines IL-17 and IL-22 (TH17 cells). Human subjects with poison-ivy dermatitis had a similar cytokine signature following CD1a-mediated recognition of urushiol. Among various urushiol congeners, we identified diunsaturated pentadecylcatechol (C15:2) as the dominant antigen for CD1a-restricted T cells. We determined the crystal structure of the CD1a-urushiol (C15:2) complex, demonstrating the molecular basis of urushiol interaction with the antigen-binding cleft of CD1a. In a mouse model and in patients with psoriasis, CD1a amplified inflammatory responses that were mediated by TH17 cells that reacted to self lipid antigens. Treatment with blocking antibodies to CD1a alleviated skin inflammation. Thus, we propose CD1a as a potential therapeutic target in inflammatory skin diseases.
Asunto(s)
Antígenos CD1/metabolismo , Autoantígenos/metabolismo , Catecoles/metabolismo , Dermatitis por Toxicodendron/inmunología , Células de Langerhans/inmunología , Psoriasis/inmunología , Células Th17/inmunología , Animales , Anticuerpos Bloqueadores/administración & dosificación , Antígenos CD1/genética , Antígenos CD1/inmunología , Catecoles/química , Cristalografía por Rayos X , Modelos Animales de Enfermedad , Humanos , Interleucina-17/metabolismo , Interleucinas/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Conformación Proteica , Toxicodendron/inmunología , Interleucina-22Asunto(s)
Dermatitis por Toxicodendron/inmunología , Tolerancia Inmunológica/fisiología , Microbiota/inmunología , Adolescente , Dermatitis por Toxicodendron/epidemiología , Dermatitis por Toxicodendron/fisiopatología , Femenino , Humanos , Tolerancia Inmunológica/inmunología , Incidencia , Israel , Masculino , América del Norte , Malezas/efectos adversos , Malezas/inmunología , Medición de Riesgo , Toxicodendron/efectos adversos , Toxicodendron/inmunología , Adulto JovenAsunto(s)
Dermatitis por Toxicodendron/patología , Inmunoglobulina G/uso terapéutico , Inmunosupresores/uso terapéutico , Psoriasis/tratamiento farmacológico , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Corticoesteroides/uso terapéutico , Dermatitis por Toxicodendron/tratamiento farmacológico , Dermatitis por Toxicodendron/inmunología , Etanercept , Humanos , Hipersensibilidad Tardía/inmunología , Masculino , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
A relationship between sensitivity to poison oak or poison ivy and mango dermatitis has been suggested by previous publications. The observation that acute allergic contact dermatitis can arise on first exposure to mango in patients who have been sensitized beforehand by contact with other urushiol-containing plants has been documented previously. We report 17 American patients employed in mango picking at a summer camp in Israel, who developed a rash of varying severity. All patients were either in contact with poison ivy/oak in the past or lived in areas where these plants are endemic. None recalled previous contact with mango. In contrast, none of their Israeli companions who had never been exposed to poison ivy/oak developed mango dermatitis. These observations suggest that individuals with known history of poison ivy/oak allergy, or those residing in area where these plants are common, may develop allergic contact dermatitis from mango on first exposure. We hypothesize that previous oral exposure to urushiol in the local Israeli population might establish immune tolerance to these plants.
Asunto(s)
Dermatitis Alérgica por Contacto/inmunología , Dermatitis por Toxicodendron/inmunología , Exposición a Riesgos Ambientales/efectos adversos , Mangifera/inmunología , Adolescente , Niño , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis por Toxicodendron/diagnóstico , Desensibilización Inmunológica , Femenino , Industria de Procesamiento de Alimentos , Humanos , Israel , Masculino , Mangifera/efectos adversos , Estudios Retrospectivos , Toxicodendron/inmunología , Viaje , Estados UnidosRESUMEN
Oral or parenteral exposure to certain contact allergens may elicit an eczematous skin reaction in sensitized individuals. This phenomenon has been called systemic contact dermatitis (SCD) and is relatively rare when compared with classical contact dermatitis. We reviewed and analysed the clinical and immunologic features of 42 patients with SCD caused by ingestion of Rhus (Toxicodendron), 24 males and 18 females, average age 44 years (range 24-72). Several of such patients (33%) had a known history of allergy to lacquer. The patients developed skin lesions such as generalized maculopapular eruptions (50%), erythroderma (29%), vesiculobullous lesions (14%) and erythema multiform (EM)-like lesions (7%). Many patients (57%) developed leucocytosis with neutrophilia (74%). In some patients (5%), abnormalities of liver function developed. We also analysed lymphocyte subsets in the peripheral blood of 12 patients. The lymphocyte subsets studied were T cells (CD3), B cells (CD19), natural killer (NK) cells (CD3-CD16+/CD56+), helper/inducer cells (CD4), cytotoxic/suppressor cells (CD8) and helper/suppressor ratio (CD4/CD8). The lymphocyte subsets of all 12 patients studied were within the normal range. Moreover, there were no differences between patients with a history of allergy to lacquer and those without a history of allergy to lacquer. Therefore, rather than an immunologic response, the skin eruption seems to be caused by a toxic reaction because of Rhus.
Asunto(s)
Dermatitis por Toxicodendron/epidemiología , Dermatitis por Toxicodendron/etiología , Plantas Tóxicas/efectos adversos , Rhus/efectos adversos , Toxicodendron/efectos adversos , Administración Oral , Adulto , Anciano , Dermatitis por Toxicodendron/inmunología , Dermatitis por Toxicodendron/patología , Femenino , Humanos , Corea (Geográfico)/epidemiología , Leucocitosis/inducido químicamente , Leucocitosis/epidemiología , Subgrupos Linfocitarios , Masculino , Registros Médicos , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
This article reviews the current fund of knowledge on poison ivy, poison oak, and poison sumac dermatitis. It is intended as a global summary to provide the primary care provider with the required information and sources for more esoteric academic pursuits. Toxicodendron characteristics, morphology, and biology are reviewed. The overall medical impact is delineated as well as the clinical manifestations, pathophysiology, prevention, and treatment. Historical perspectives are mentioned throughout, as are future trends in research.
Asunto(s)
Dermatitis por Toxicodendron/prevención & control , Dermatitis por Toxicodendron/clasificación , Dermatitis por Toxicodendron/inmunología , Dermatitis por Toxicodendron/fisiopatología , HumanosRESUMEN
The objective of the studies was to demonstrate that the contact sensitivity (CS) response to poison ivy/oak could be downregulated following treatment with a monoclonal antibody (mAb) reacting with the allergen urushiol. Conjugation of urushiol and its synthetic analogue 3-n-pentadecylcatechol (PDC) to N-acetylcysteine yielded hydrosoluble derivatives which induced humoral immune responses in BALB/c mice. Hybridomas secreting monoclonal antibodies (mAbs) reacting with urushiol and PDC were generated by fusion of B lymphocytes from immunized mice with mouse myeloma P3NS0 cells. The specificity of mAb ALG 991 (IgM isotype) was defined by inhibition of antibody binding by PDC analogues. This demonstrated that mAb ALG 991 reacted with the catechol moiety of urushiol, the region of the allergen being critically important in the induction of contact dermatitis. The CS response to urushiol in BALB/c mice was suppressed by stimulation with mAb ALG 991 and the role of sensitized T cells, including suppressor T cells, has been considered. Suppression of CS was most effective with low doses (1 microg) of mAb incorporated into a vaccine with Freund's adjuvant. This treatment suppressed CS responses in BALB/c mice already sensitized to urushiol.
Asunto(s)
Anticuerpos Monoclonales/farmacología , Catecoles/antagonistas & inhibidores , Catecoles/toxicidad , Dermatitis por Toxicodendron/inmunología , Dermatitis por Toxicodendron/prevención & control , Alérgenos , Animales , Especificidad de Anticuerpos , Catecoles/inmunología , Regulación hacia Abajo , Femenino , Hibridomas/inmunología , Inmunización , Idiotipos de Inmunoglobulinas/sangre , Terapia de Inmunosupresión , Ratones , Ratones Endogámicos BALB C , Plantas Tóxicas , Toxicodendron/toxicidadRESUMEN
Immune regulation of contact sensitivity to the poison ivy/oak catechol was studied at the level of class II MHC-restricted T cell recognition of hapten:peptide conjugates. In this study we have shown that 1) T cells from C3H/HeN (H-2k) mice, immunized with a synthetic I-Ak binding peptide coupled to 3-pentadecyl-catechol (PDC; a representative catechol in urushiol), recognized peptides derived from syngeneic cells linked to the same catechol; 2) T cells from draining lymph nodes of C3H/HeN mice skin-painted with PDC proliferated in response to a peptide carrier:PDC conjugate only when it was linked at the 7th, but not the 4th or the 10th, position on the peptide carrier; and 3) tolerization studies confirmed down-regulation of PDC-induced delayed-type hypersensitivity following treatment with a single I-Ak binding peptide carrying PDC covalently bound to a lysine residue at the middle (7th) TCR contact position. Tolerization with peptide:PDC conjugate resulted in abrogation of hapten-specific T cell proliferative responses that correlated with diminished IL-2 secretion. On the basis of these data we propose that it may be sufficient to couple the hapten at a single, well-chosen position on a carrier peptide to target a relevant population of T cells involved in contact sensitivity.
Asunto(s)
Proteínas Portadoras/uso terapéutico , Dermatitis por Toxicodendron/inmunología , Regulación hacia Abajo/inmunología , Haptenos/uso terapéutico , Antígenos de Histocompatibilidad Clase II/metabolismo , Trinitrobencenos/uso terapéutico , Administración Tópica , Animales , Proteínas Portadoras/síntesis química , Proteínas Portadoras/química , Catecoles/administración & dosificación , Catecoles/síntesis química , Catecoles/química , Dermatitis por Toxicodendron/prevención & control , Haptenos/inmunología , Tolerancia Inmunológica/efectos de los fármacos , Interleucina-2/metabolismo , Activación de Linfocitos/efectos de los fármacos , Ratones , Ratones Endogámicos A , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Péptidos/metabolismo , Péptidos/fisiología , Unión Proteica/efectos de los fármacos , Unión Proteica/inmunología , Piel/inmunología , Linfocitos T/inmunología , Linfocitos T/metabolismo , Trinitrobencenos/inmunologíaRESUMEN
Abstract: Epidermal keratinocytes in culture have been shown to produce many cytokines, and their proteins have been identified in skin tissue samples. It has therefore been assumed that these cytokines are transcribed in vivo by the epidermis in response to contact allergens. In this report, in situ hybridization was used to detect the messenger RNAs for interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta) and tumour necrosis factor-alpha (TNF-alpha) in samples of human skin prior to and at various times after application of urushiol, the immunogenic component of poison ivy/oak. In sensitive subjects, IL-1 alpha and TNF-alpha mRNAs showed a progressive increase in transcript levels that paralleled the clinical and histological features of the inflammatory process. The time-course of the IL-1 beta response differed from that of IL-1 alpha and TNF-alpha, in that there was an early (by 6 h after urushiol administration) elevation in IL-1 beta mRNA that occurred before there was evidence of inflammation and had returned to background levels by 72 h when the reaction had reached its peak. In contrast to urushiol-sensitive subjects, urushiol-anergic individuals did not exhibit an increase in IL-1 alpha, IL-1 beta or TNF-alpha mRNA levels. The data provide evidence for an in vivo role for epidermal IL-1 alpha, IL-1 beta and TNF-alpha transcription in the regulation of IL-1 beta and TNF-alpha polypeptide levels in the epidermis in response to this common contact allergen.
Asunto(s)
Catecoles/toxicidad , Citocinas/biosíntesis , Dermatitis por Toxicodendron/inmunología , Plantas Tóxicas , ARN Mensajero/biosíntesis , Piel/efectos de los fármacos , Toxicodendron , Transcripción Genética/efectos de los fármacos , Adulto , Dermatitis por Toxicodendron/patología , Dermatitis por Toxicodendron/fisiopatología , Edema , Eritema , Humanos , Interleucina-1/biosíntesis , Piel/inmunología , Piel/patología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/biosíntesisRESUMEN
Among the growing and diverse groups of outdoor and environmental workers, poison ivy and poison oak continue to be the major cause of occupational contact dermatitis. This article reviews the practical and theoretic means to prevent poison ivy and poison oak dermatitis in workers occupationally exposed to these weeds.
Asunto(s)
Dermatitis Profesional/etiología , Dermatitis por Toxicodendron/etiología , Catecoles/inmunología , Dermatitis Profesional/inmunología , Dermatitis Profesional/prevención & control , Dermatitis por Toxicodendron/inmunología , Dermatitis por Toxicodendron/prevención & control , Humanos , Plantas Tóxicas , ToxicodendronRESUMEN
Induction of allergic contact dermatitis over warts (verrucae vulgaris) causes viral immunity and resolution of the warts in a large percentage of cases. Human immunodeficiency virus could be removed, concentrated, and placed back into the patient's own skin at a site of contact dermatitis.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , Dermatitis por Contacto/inmunología , Infecciones por VIH/inmunología , VIH , Inmunoterapia/métodos , Verrugas/terapia , Síndrome de Inmunodeficiencia Adquirida/terapia , Dermatitis por Toxicodendron/inmunología , Dinitroclorobenceno , Infecciones por VIH/terapia , Humanos , Verrugas/inmunologíaRESUMEN
To understand the molecular events which are important in leucocyte trafficking in cutaneous inflammation, poison ivy/oak extract was applied topically to the skin, and the simultaneous assessment of a variety of clinical and immunopathological parameters performed. The clinical response of subjects was divided into three main groups: I, 2-24h after application, before the onset of erythema; II, 48 h-1 week after application during maximal clinical changes; III, 2-3 weeks after application when the inflammation had subsided. Six different biopsies per subject were evaluated over the study period and the density of dermal cellular infiltrate, and the distribution of intercellular adhesion molecule-1, (ICAM-1), endothelial leucocyte adhesion molecule-1, (ELAM-1), vascular cell adhesion molecule-1, (VCAM-1), interleukin 8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha), determined. Eight hours after exposure, before lymphocytes and monocytes had entered the dermal interstitium or epidermis, the keratinocytes expressed TNF-alpha and ICAM-1, whilst the endothelial cells expressed ELAM-1, VCAM-1 and ICAM-1. Group II biopsies revealed increasing keratinocyte expression of TNF-alpha and ICAM-1 with the appearance of IL-8, which correlated with the onset of epidermal T-cell trafficking. The endothelium was strongly positive for ELAM-1 and VCAM-1, but there was no influx of neutrophils. Group III biopsies showed a decrease in the expression of ICAM-1, VCAM-1 and ELAM-1 by both keratinocytes and endothelium with a reduction in epidermal/dermal inflammation, although the endothelial cell staining of VCAM-1 and ELAM-1 did not completely disappear. These results suggest that on exposure to poison ivy/oak, keratinocytes rapidly produce TNF-alpha which leads to an early autoinduction of ICAM-1, and later IL-8. There is also a paracrinemediated induction and augmentation of underlying endothelial cell ELAM-1, VCAM-1 and ICAM-1.
Asunto(s)
Moléculas de Adhesión Celular/metabolismo , Dermatitis por Toxicodendron/inmunología , Interleucina-8/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adulto , Movimiento Celular , Dermatitis por Toxicodendron/patología , Selectina E , Endotelio/metabolismo , Endotelio/patología , Femenino , Humanos , Inmunohistoquímica , Molécula 1 de Adhesión Intercelular , Queratinocitos/metabolismo , Queratinocitos/patología , Masculino , Persona de Mediana Edad , Linfocitos T/patología , Factores de Tiempo , Molécula 1 de Adhesión Celular VascularRESUMEN
The pathophysiology and immune mechanisms involved in the clinical syndrome of autoeczematization remain a mystery. In this study of nickel dermatitis without autoeczematization and poison oak dermatitis with autoeczematization, it was noted that the process of autoeczematization was associated with the presence of CD8+ lymphocytes within the epidermis and the expression of HLA-DR antigens on epidermal keratinocytes. It is surmised that since CD8+ clones are induced by poison oak antigen but not by nickel, the inability of nickel to induce CD8+ lymphocytes may explain why uncomplicated nickel dermatitis does not autoeczematize. Since the selective adherence of CD8+ lymphocytes to keratinocytes, probably via the expression of adhesion molecules such as ICAM-1, the generation of antigens on endothelial cells of high endothelial venules involved in lymphocyte trafficking, and the expression of HLA-DR antigens on epidermal keratinocytes are all due to the activity of interferon-8, it is deduced that this lymphokine may play a key role in id eruptions induced by contact allergens.
Asunto(s)
Antígenos CD8/análisis , Dermatitis por Toxicodendron/inmunología , Subgrupos Linfocitarios/inmunología , Dermatitis por Contacto/inmunología , Dermatitis por Toxicodendron/patología , Eccema/inmunología , Eccema/patología , Antígenos HLA-DR/análisis , Humanos , Subgrupos Linfocitarios/patología , Níquel/efectos adversosRESUMEN
The frequencies of urushiol (poison ivy)-specific T cells were determined in the lesional skin and peripheral blood of patients with allergic contact dermatitis to urushiol. Lesions of urushiol dermatitis were biopsied and the T cells retrieved. Frequencies of Ag-specific cells were determined by limiting dilution assay. Enrichment of urushiol specific T cells was detected in lesional skin or blister fluid of five of five of these donors as well as seven of seven donors with urushiol patch tests. There was also enrichment relative to tetanus toxoid specific T cells in blood and skin of six of seven donors. The frequency of lesional T cells specific for urushiol was less than 1/100 and generally less than 1/1000. Furthermore, the frequency of urushiol specific T cells was often less than 1/10,000 in the peripheral blood during an acute eruption. Autoreactive T cells that proliferated to autologous irradiated PBMC were also enriched in skin lesions relative to blood in 5/5 urushiol patch tests. These autoreactive T cells were expanded and found to be CD4+. It has been proposed that such autoreactive T cells recognize autologous DR and may have a role in immunoregulation. Urushiol-specific T cells were expanded from limiting dilution wells of two donors and characterized. The majority of the urushiol-specific cells were CD8+, and 13/43 lines were suppressive for PWM-induced IgG synthesis.
Asunto(s)
Catecoles/inmunología , Dermatitis por Toxicodendron/inmunología , Plantas Tóxicas , Linfocitos T/inmunología , Antígenos de Diferenciación de Linfocitos T/análisis , Antígenos CD4/análisis , Antígenos CD8 , Dermatitis por Toxicodendron/etiología , Humanos , Inmunoglobulina G/biosíntesis , Toxoide Tetánico/inmunologíaRESUMEN
Drug-induced, photosensitive erythema multiforme has not been reported, although drugs and sunlight are listed among precipitating factors in erythema multiforme. We describe a case of a drug-induced erythema multiforme-like eruption in a photodistribution that was reproduced by clinical challenge with the drug and sunlight. On contact with Rhus verniciflua, the Japanese lacquer tree, the patient had a flare of the eruption, which was limited to the areas previously exposed to sun. Immunohistochemical studies suggested that the keratinocytes in the skin that retain teh photoactivated substances may facilitate epidermal invasion of lymphocytes by persistent expression of intercellular adhesion molecule-1.
Asunto(s)
Moléculas de Adhesión Celular/análisis , Dermatitis por Toxicodendron/etiología , Erupciones por Medicamentos/etiología , Eritema Multiforme/inducido químicamente , Trastornos por Fotosensibilidad/inducido químicamente , Quinazolinas/efectos adversos , Adulto , Anticuerpos Monoclonales , Dermatitis por Toxicodendron/inmunología , Erupciones por Medicamentos/inmunología , Eritema Multiforme/inmunología , Antígenos HLA-DR/análisis , Humanos , Molécula 1 de Adhesión Intercelular , Queratinocitos/inmunología , Masculino , Trastornos por Fotosensibilidad/inmunología , Pruebas CutáneasRESUMEN
Proper use of patch testing to identify the causes of contact dermatitis requires that the physician use the test where it will have the highest likelihood of benefit. Identifying endogenous dermatoses by morphologic and historical criteria and distinguishing these from likely cases of exogenous dermatoses prior to testing will enhance the number of people helped by applying the patch test procedure. Knowledge of the technical aspects of patch testing and how to instruct patients with positive and negative tests is an essential part of solving complex contact dermatitis problems.